NorthSea Therapeutics is a Pan-European biotech company
Northsea Therapeutics has raised €106M across 2 funding rounds from 8 investors, most recently a round in Dec 2021. Based in Naarden, Netherlands; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-12-17 | Other | €71M | BGV,Forbion Capital Partners,Forbion Growth,New Science Ventures,Novo Seeds,Sofinnova Partners+2 more | View deal → |
| 2020-01-08 | Series B | €36M | venBio Partners | View deal → |
